Li Ge, MD
Medical Oncology Physician in Fresno, California. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,792 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Li Ge, MD reported a CMS MIPS final score of 85.8/100 - above the 83.1 national average - and filed 741 Medicare Part D claims in 2023.
- 85.8/100
- MIPS score · +3 vs avg
- 741
- Part D claims, 2023
- 89%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Li Ge, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
86 49th percentile higher than 49% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Li Ge, MD sits
This provider among medical oncology physician peers
Across the 1,527 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Li Ge, MD writes more Part D claims than 63% of them and scores higher on MIPS quality than 49% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Li Ge, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Li Ge, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Li Ge, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Medical Oncology Physician compares to other specialties among California providers
Largest specialties in California (% of in-state providers)
Medical Oncology Physician ranks #177 among California's specialties (0% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Medical Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Li Ge, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 85.8/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) - 85.8/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Medical Oncology Physician US NPIs
85.8/100 MIPS final score - 2.7 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Medical Oncology Physician. Quality dim: 91.3. Cost dim: 61.3.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Li Ge, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 6121 N THESTA ST STE 204, Fresno, CA, 93710, with a listed phone of (559) 438-7390. NPI 1194709188 was issued on 12/02/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Ge most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 741 prescription claims written by this provider, covering 225 Medicare beneficiaries and totaling roughly $655K in drug spend, split 11% brand-name and 89% generic by claim count, with an opioid prescribing rate of 1.6%. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 85.8/100 for the 2023 performance year (Quality 91.3, Cost 61.3), compared with the national average of 83.1.
Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1194709188 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 12/02/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Li Ge, MD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Li Ge, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Li Ge, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.5K
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Li Ge, MD. To verify Li Ge, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
11% brand-name claims vs 89% generic, on 741 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,386
- Total Day Supply
- 39,267
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $620K
- Generic Drug Cost
- $35K
- Opioid Claims
- 12 (1.6% rate)
- Antibiotic Claims
- 20
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.40
- Age Distribution
- <65: 17, 65-74: 115, 75-84: 77, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Li Ge, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
300 claims
- Tamoxifen Citrate 69
Tamoxifen Citrate
69 claims
- Exemestane 50
Exemestane
50 claims
- Alendronate Sodium 49
Alendronate Sodium
49 claims
- Prochlorperazine M… 39
Prochlorperazine Maleate
39 claims
- Ibrance 26
Ibrance
26 claims
- Letrozole 24
Letrozole
24 claims
- Dexamethasone 16
Dexamethasone
16 claims
| Drug | Claims |
|---|---|
| Anastrozole | 300 |
| Tamoxifen Citrate | 69 |
| Exemestane | 50 |
| Alendronate Sodium | 49 |
| Prochlorperazine Maleate | 39 |
| Ibrance Palbociclib | 26 |
| Letrozole | 24 |
| Dexamethasone | 16 |
| Gabapentin | 13 |
| Eliquis Apixaban | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Li Ge, MD fits within the Medical Oncology Physician landscape nationally.
Li Ge, MD's 741 claims are above the specialty average of 689.
Nearby Medical Oncology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Ge.
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is Li Ge, MD's specialty? ▼
How much does Li Ge, MD prescribe under Medicare Part D? ▼
What is Li Ge, MD's Medicare quality score? ▼
Where is Li Ge, MD located? ▼
What is Li Ge, MD's NPI number? ▼
Does Li Ge, MD prescribe more brand-name or generic drugs? ▼
Does Li Ge, MD prescribe opioids? ▼
How many Medical Oncology Physician providers are there in the US? ▼
What drugs does Li Ge, MD prescribe most often? ▼
Does Li Ge, MD accept Medicare? ▼
How can I verify Li Ge, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology